GL1X · GenesisL1 explorer

Research workbench

Optimization of potent and selective atm inhibitors suitable for a proof-of-concept study in HUNTINGTON'S disease models

Analyse Optimization of potent and selective atm inhibitors suitable for a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6I3U
Type
protein
Length
557 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 3-kinase catalytic subunit type 3
EC
2.7.1.137
UniProt
Q8NEB9
Ligands
H2E
Pockets
4 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 58% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 3-kinase catalytic subunit type 3 (EC 2.7.1.137)protein55758% helix, 8% strandQ8NEB9

Ligands and binding sites

  • H2E · 2-morpholin-4-yl-6-[7-[(2~{R})-1-morpholin-4-ylpropan-2-yl]oxy-9~{H}-thioxanthen-4-yl]pyran-4-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12550.600.7931H2E
21640.580.8220empty
31090.380.7521empty
4690.290.7418empty

Compared structures

  • 6I3U · Optimization of potent and selective ATM inhibitors suitable for a proof-of-concept study… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8NEB9 · AlphaFold monomer V2.0 prediction for phosphatidylinositol 3-kinase catalytic subunit… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.